IL33 and neoplasm: In brief, although the exact mechanism of enhanced IL-33 expression remains undetermined, we were able to show that hyperactivation of IL-33 facilitates a DNA damage-resistant TME through both the paracrine pathway from CAFs and the autocrine pathway from tumor cells (Supplementary Fig. S6 model).